Physician profile
Jenna L Hilton
NPI 1558593632
$637,130.16
in general payments reported to CMS, 2019-2025
7 companies · $227K in 2025
The $227K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $304 · 2022: $24K · 2023: $151K · 2024: $235K · 2025: $227K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $549K · Travel and Lodging: $53K · Food and Beverage: $10K · Consulting Fee: $670 · Education: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $548,630.81 |
| Travel and Lodging | $53,485.72 |
| Food and Beverage | $10,061.04 |
| Consulting Fee | $670.00 |
| Education | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $606,392.95 | 2022-2025 | |
| Allergan, INC. | $23,884.20 | 2021-2022 | |
| Galderma Laboratories, L.P. | $6,218.49 | 2021-2024 | |
| Merz North America, INC. | $484.52 | 2022-2025 | Xeomin |
| Botanix Sb INC | $114.84 | 2025 | Sofdra |
| Abbott Laboratories | $19.28 | 2021 | |
| Glaxosmithkline, LLC. | $15.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Hilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.